In a multicenter, retrospective study, researchers evaluated time from NMOSD onset to serological diagnosis and factors associated with predicting shorter time to diagnosis.
Delay in diagnosis is one of the biggest challenges in treating patients with neuromyelitis optica disorder (NMOSD). What factors contribute to a delay in diagnosing NMOSD? Take the quiz to test your...
Neuromyelitis optica spectrum disorder was previously believed to be a variant of multiple sclerosis, but recent literature has highlighted clinical characteristics that differentiate the diseases. Take...
New research reveals significant mental health challenges among patients with neuromyelitis optica spectrum disorders. Can you correctly identify the prevalence of certain psychological issues in these...
In this video, Mirla Avila, MD, discusses how managing neuromyelitis optica disorder has evolved in the past decade, patient access to FDA-approved treatment options for neuromyelitis optica spectrum...
